ATI incubator pulls BioVent away from IPO
Globes - 14 minutes ago
ATI believes that it is premature for BioVent to go public, since the company's flu drug is still at the preclinical development stage. Ashkelon Technological Industries (ATI) has decided not to ...
http://digg.com/u1UOBy
No comments:
Post a Comment